新冠疫情后神经性疼痛患病率增加的可能性。
Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic.
作者信息
Attal Nadine, Martinez Valéria, Bouhassira Didier
机构信息
INSERM U 987, CETD, Hôpital Ambroise Paré, APHP, Boulogne-Billancourt, France.
Université Versailles Saint Quentin, Versailles, France.
出版信息
Pain Rep. 2021 Jan 27;6(1):e884. doi: 10.1097/PR9.0000000000000884. eCollection 2021 Jan-Feb.
Abstract
Although coronavirus disease 2019 (COVID-19) most commonly manifests with acute respiratory symptoms, one very common symptom of COVID-19 is pain. As COVID-19 often causes peripheral or central neurological complications, it is anticipated that a number of the chronic pain complications of COVID-19 will be neuropathic. This review first examines the most common viral infections responsible for neurological complications including neuropathic pain. These encompass herpes zoster, HIV, poliovirus, enteroviruses, and several tropical viruses. Neurological complications of COVID-19 including in particular Guillain-Barré syndrome, myelitis, and stroke are reviewed with regards to their potential risk of chronic neuropathic pain. Prospective longitudinal cohorts of patients should be implemented to evaluate the exact risk of neuropathic pain after COVID-19.
摘要
尽管2019冠状病毒病（COVID-19）最常见的表现是急性呼吸道症状，但疼痛是COVID-19非常常见的症状之一。由于COVID-19常引起外周或中枢神经系统并发症，预计COVID-19的一些慢性疼痛并发症将是神经性的。本综述首先研究了导致包括神经性疼痛在内的神经系统并发症的最常见病毒感染。这些包括带状疱疹病毒、艾滋病毒、脊髓灰质炎病毒、肠道病毒和几种热带病毒。本文就COVID-19的神经系统并发症，特别是格林-巴利综合征、脊髓炎和中风，对其慢性神经性疼痛的潜在风险进行了综述。应实施患者前瞻性纵向队列研究，以评估COVID-19后神经性疼痛的确切风险。
相似文献
1
Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic.
Pain Rep. 2021 Jan 27;6(1):e884. doi: 10.1097/PR9.0000000000000884. eCollection 2021 Jan-Feb.
2
Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
Rev Neurol (Paris). 2021 Jan-Feb;177(1-2):51-64. doi: 10.1016/j.neurol.2020.10.001. Epub 2020 Dec 16.
3
Pain during and after COVID-19 in Germany and worldwide: a narrative review of current knowledge.
Pain Rep. 2021 Jan 20;6(1):e893. doi: 10.1097/PR9.0000000000000893. eCollection 2021 Jan-Feb.
4
Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
J Neurol. 2021 Sep;268(9):3059-3071. doi: 10.1007/s00415-021-10406-y. Epub 2021 Jan 23.
5
Neurological Complications Associated With SARS-CoV-2 Infection: A Single-Centre Experience.
Cureus. 2022 Dec 18;14(12):e32655. doi: 10.7759/cureus.32655. eCollection 2022 Dec.
6
Spectrum of Neurological Manifestations in Covid-19: A Review.
Neurol India. 2020 May-Jun;68(3):560-572. doi: 10.4103/0028-3886.289000.
7
[Bifacial weakness with paresthesia – a rare Guillain–Barré syndrome subtype associated with SARS-CoV-2 infection].
Orv Hetil. 2021 Nov 7;162(45):1803-1807. doi: 10.1556/650.2021.32355.
8
Cohort study protocol to characterize the incidence and severity of neuropathic pain in patients with severe acute respiratory syndrome coronavirus 2 infection.
Pain Rep. 2021 Apr 20;6(1):e925. doi: 10.1097/PR9.0000000000000925. eCollection 2021.
9
Coronavirus Disease 2019 (COVID-19) From the Point of View of Neurologists: Observation of Neurological Findings and Symptoms During the Combat Against a Pandemic.
Noro Psikiyatr Ars. 2020 May 1;57(2):154-159. doi: 10.29399/npa.26148. eCollection 2020 Jun.
10
Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Neurol Sci. 2020 Oct;41(10):2657-2669. doi: 10.1007/s10072-020-04575-3. Epub 2020 Jul 28.
引用本文的文献
1
Prescription rates in different groups of outpatients with covid-19 and other acute respiratory infections: comparative observational study based on German routine data.
BMJ Med. 2025 Sep 4;4(1):e000992. doi: 10.1136/bmjmed-2024-000992. eCollection 2025.
2
Post-acute sequelae SARS-CoV-2 infection and neuropathic pain: a narrative review of the literature and future directions.
Pain Manag. 2025 Jun;15(6):333-343. doi: 10.1080/17581869.2025.2501521. Epub 2025 May 14.
3
Exploring the Potential of Dietary Supplements to Alleviate Pain Due to Long COVID.
Nutrients. 2025 Apr 7;17(7):1287. doi: 10.3390/nu17071287.
4
Alcohol Consumption Modulates the Development of Chronic Pain in COVID-19 Patients: A Network Meta-Analysis.
ACS Pharmacol Transl Sci. 2025 Feb 4;8(2):409-422. doi: 10.1021/acsptsci.4c00479. eCollection 2025 Feb 14.
5
Neuropathic component of chronic musculoskeletal pain in patients with post-COVID-19: A cross-sectional study.
Arch Rheumatol. 2024 Aug 26;39(3):436-446. doi: 10.46497/ArchRheumatol.2024.9990. eCollection 2024 Sep.
6
A narrative review of the complex panorama regarding chronic neuropathic pain mainly for the psychological issues.
Heliyon. 2024 Sep 21;10(19):e38282. doi: 10.1016/j.heliyon.2024.e38282. eCollection 2024 Oct 15.
7
Peripheral Nerve Stimulation for Neuropathic Pain Management: A Narrative Review.
Pain Ther. 2024 Dec;13(6):1387-1406. doi: 10.1007/s40122-024-00659-6. Epub 2024 Sep 28.
8
Prevalence and Management of Chronic Pain, Including Neuropathic Pain, in Dialysis Patients with End-Stage Renal Disease.
Med Sci Monit. 2024 May 16;30:e943808. doi: 10.12659/MSM.943808.
9
Research progress of post-acute sequelae after SARS-CoV-2 infection.
Cell Death Dis. 2024 Apr 11;15(4):257. doi: 10.1038/s41419-024-06642-5.
10
Pain types and risk factors in post-COVID-19.
Turk J Phys Med Rehabil. 2024 Feb 1;70(1):30-38. doi: 10.5606/tftrd.2024.13828. eCollection 2024 Mar.
本文引用的文献
1
Finding the 'right' GP: a qualitative study of the experiences of people with long-COVID.
BJGP Open. 2020 Dec 15;4(5). doi: 10.3399/bjgpopen20X101143. Print 2020 Dec.
2
The lingering manifestations of COVID-19 during and after convalescence: update on long-term pulmonary consequences of coronavirus disease 2019 (COVID-19).
Radiol Med. 2021 Jan;126(1):40-46. doi: 10.1007/s11547-020-01295-8. Epub 2020 Oct 1.
3
As Their Numbers Grow, COVID-19 "Long Haulers" Stump Experts.
JAMA. 2020 Oct 13;324(14):1381-1383. doi: 10.1001/jama.2020.17709.
4
Neurological disease in adults with Zika and chikungunya virus infection in Northeast Brazil: a prospective observational study.
Lancet Neurol. 2020 Oct;19(10):826-839. doi: 10.1016/S1474-4422(20)30232-5. Epub 2020 Sep 16.
5
Injury-prone: peripheral nerve injuries associated with prone positioning for COVID-19-related acute respiratory distress syndrome.
Br J Anaesth. 2020 Dec;125(6):e478-e480. doi: 10.1016/j.bja.2020.08.045. Epub 2020 Sep 4.
6
Neuromuscular presentations in patients with COVID-19.
Neurol Sci. 2020 Nov;41(11):3039-3056. doi: 10.1007/s10072-020-04708-8. Epub 2020 Sep 15.
7
The lasting misery of coronavirus long-haulers.
Nature. 2020 Sep;585(7825):339-341. doi: 10.1038/d41586-020-02598-6.
8
A Case Report of Acute Transverse Myelitis Following Novel Coronavirus Infection.
Clin Pract Cases Emerg Med. 2020 Aug;4(3):321-323. doi: 10.5811/cpcem.2020.5.47937.
9
Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
PLoS Med. 2020 Sep 8;17(9):e1003308. doi: 10.1371/journal.pmed.1003308. eCollection 2020 Sep.
10
Effects of COVID-19 on the Nervous System.
Cell. 2020 Oct 1;183(1):16-27.e1. doi: 10.1016/j.cell.2020.08.028. Epub 2020 Aug 19.
Zotero 插件